ATS 2018 International Conference - Mobile

Peter Wessman

PhD

AstraZeneca

Session(s)

Efficacy and Safety of Tralokinumab in Two Phase III Trials of Severe, Uncontrolled Asthma...
Sunday, May 20 2:15 PM - 4:15 PM